Pseudarthrosis is one of the main causes of pain after surgery. However, in around 30% of cases, people with this condition have no symptoms.

Congenital pseudarthrosis of the tibia: a review of the literature and 52 cases from the Mayo Clinic. Clin Orthop 1974; 99: 140–145. Article Google Scholar McFarland B .

More information: Ruslan Masgutov et al, Use of Gene-Activated Demineralized Bone Allograft in the Therapy of Ulnar Pseudarthrosis. Case Report, BioNanoScience (2016). DOI: 10.1007/s12668-016-0325-7 ...

Overall, the rate of symptomatic pseudarthrosis was 1.9% in the BMP group and 1.4% in the control group. The researchers noted BMP use during the procedure was associated with a 44% increased risk ...

The prospective study conducted at 10 centers across the U.S. analyzed a total of 142 patients with one or more risk factors for pseudarthrosis.

The FDA cleared an investigational new drug application for NVD-003, a stem cell therapy for treatment of children with congenital pseudarthrosis of the tibia, according to the agent’s ...

Our therapy, a combination of demineralized bone with gene therapy, is a promising solution for the currently existing complication problems in pseudarthrosis and other bone defects and fracture ...

Pseudarthrosis occurred in 9.82 percent of nonsmokers and 7.69 percent of smokers (P = 0.738).

PROTOCOL Children with NF1 and tibial pseudarthrosis whose primary orthopedic surgeon deems surgical intervention is required are eligible for this trial. At time of enrollment, participants will be ...

Our therapy, a combination of demineralized bone with gene therapy, is a promising solution for the currently existing complication problems in pseudarthrosis and other bone defects and fracture ...

YOU did it Gold Coast. Little William Dickinson is off to the USA for surgery to treat his congenital pseudarthrosis after his mum Aimee rallied the city to raise $185,000. In just eight months ...